Европска Унија -
Енглески -
EMA (European Medicines Agency)
oprymea
krka, d.d., novo mesto - pramipexole dihydrochloride monohydrate - parkinson disease - anti-parkinson drugs - oprymea is indicated for treatment of the signs and symptoms of idiopathic parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on off" fluctuations).oprymea is indicated in adults for symptomatic treatment of moderate to severe idiopathic restless legs syndrome in doses up to 0.54 mg of base (0.75 mg of salt) (see section 4.2).
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 0.26mg modified-release tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 260microgram
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 1.57mg modified-release tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 1.57mg
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 2.1mg modified-release tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 2.1mg
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 0.52mg modified-release tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 520microgram
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 1.05mg modified-release tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 1.05mg
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 3.15mg modified-release tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 3.15mg
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 2.62mg modified-release tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 2.62mg
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 0.088mg tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 88microgram
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
oprymea 0.18mg tablets
consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 180microgram